YOLFTbeta
Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc

KALA · NASDAQ · Healthcare / Biotechnology

0.1388USD-0.02 (-13.79%)

Price History

Full chart

Market Stats

Previous Close0.161
Open0.1496
Day Range0.132 – 0.151
52-Week Range0.4314 – 95.50
Volume936.81K
Market Cap9.20M
P/E (TTM)0.00
Forward P/E0.00
EPS-9.39
Dividend Yield0.00%
Beta-2.29
50-Day Avg0.6985
200-Day Avg10.91

About

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Avi Minkowitz
  • Employees6
  • Headquarters1167 Massachusetts Avenue, Arlington, MA, United States, 02476, USA
  • Websitehttps://www.kalarx.com

Leadership

  • Ms. Mary Reumuth CPATreasurer & Secretary · b. 1975
  • Mr. Avi MinkowitzCEO, CFO & Director · b. 1988
  • Dr. Justin Hanes Ph.D.Founder & Chair of the Scientific Advisory Board
  • Ms. Jill S. SteierExecutive Director of Investor Relations & Corporate Communications
  • Mr. Vincent KosewskiSenior VP of Manufacturing & Supply Chain Management · b. 1963
  • Dr. Francis S. Mah M.D.Chief Medical Advisor
  • Mr. Josiah Craver CPASenior VP & Corporate Controller
  • Mr. Carl RennieExecutive Director of Account Management
  • Mr. Patrick BedellExecutive Director of Trade & Alternate Channels

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue50.00K455.00K45.00K0006.07M6.36M11.24M3.89M000
Growth (%)-+810.00%-90.11%-100.00%---+4.74%+76.67%-65.37%-100.00%--
Cost of Revenue50.00K455.00K15.66M297.00K643.00K955.00K2.85M3.17M4.10M2.56M303.00K259.00K317.00K
Gross Profit--13.40M45.00K-297.00K-643.00K-955.00K3.23M3.19M7.14M1.33M-303.00K-259.00K-317.00K
Gross Margin--2945.93%100.00%---53.11%50.13%63.55%34.22%---
Operating Expense-4.44M15.99M32.37M39.23M63.77M91.45M99.42M116.58M82.69M38.85M40.17M38.84M
Operating Income-11.13M-17.84M-15.95M-32.67M-39.88M-64.72M-88.22M-96.23M-109.43M-81.36M-39.15M-40.43M-39.16M
Operating Margin-22264.00%-3920.88%-35435.56%----1452.49%-1512.59%-973.60%-2090.34%---
EBITDA-10.93M-17.54M-15.62M-32.37M-39.23M-63.77M-85.61M-93.39M-131.96M-36.70M-36.08M-32.47M-23.39M
EBITDA Margin-21862.00%-3855.38%-34702.22%----1409.42%-1468.01%-1173.99%-942.86%---
Net Income-10.65M-19.36M-16.68M-33.17M-42.21M-66.74M-94.35M-104.33M-142.60M-44.82M-42.20M-38.51M-26.98M
Net Income Margin-21306.00%-4255.16%-37071.11%----1553.29%-1639.85%-1268.73%-1151.64%---
R&D7.73M13.86M11.38M25.03M29.01M29.29M26.96M18.35M11.52M17.65M18.59M21.84M18.78M
R&D as % of Total Revenue15468.00%3045.93%25293.33%---443.81%288.46%102.45%453.57%---
Interest Expense191.00K1.61M604.00K767.00K1.02M3.31M8.48M8.59M8.38M7.27M5.81M5.78M3.28M
Interest Expense % of Total Revenue382.00%353.41%1342.22%---139.61%135.00%74.56%186.69%---

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.07M11.72M8.45M46.33M116.13M220.97M154.32M221.61M139.43M86.82M55.95M55.48M9.49M
Total Liabilities6.87M8.46M14.24M134.09M26.45M115.98M124.63M121.61M122.62M67.85M48.45M43.15M2.49M
Total Equity202.00K3.26M-5.79M-87.76M89.68M104.99M29.69M100.00M16.80M18.97M7.50M12.33M7.00M
Cash5.34M10.62M5.76M45.47M114.56M170.90M85.45M77.26M92.14M70.50M50.90M51.18M7.56M
Total Debt4.67M4.66M9.79M9.65M18.65M99.44M101.18M100.92M80.19M42.95M36.32M32.25M-
Net Debt-667.00K-5.96M4.04M-35.82M-95.91M-71.46M15.73M23.65M-11.95M-27.55M-14.57M-18.93M-7.56M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.84M-15.36M-15.09M-27.35M-34.10M-54.12M-92.72M-90.69M-108.23M-78.91M-27.93M-29.38M-31.99M
Investing Cash Flow-841.00K-182.00K-252.00K-153.00K-480.00K-1.58M-1.33M-78.21M70.80M62.72M-429.00K-208.00K-15.00K
Financing Cash Flow15.95M20.85M10.48M67.21M103.70M124.10M8.98M160.63M42.55M-7.94M8.51M29.88M-11.62M
Capital Expenditure789.00K225.00K252.00K153.00K480.00K1.58M1.33M1.94M886.00K313.00K610.00K208.00K15.00K
Free Cash Flow-11.63M-15.59M-15.34M-27.50M-34.58M-55.70M-94.06M-92.64M-109.12M-79.22M-28.54M-29.59M-31.99M
Dividends Paid----0-----365.00K--
FCF to OCF107.28%101.46%101.67%100.56%101.41%102.92%101.44%102.14%100.82%100.40%102.18%100.71%100.00%
Dividend Paid to FCF----0.00%------1.28%--

Earnings

Report DateMay 31, 2017Aug 31, 2017Nov 7, 2017Mar 26, 2018May 10, 2018Aug 9, 2018Nov 8, 2018Mar 11, 2019May 9, 2019Aug 6, 2019Nov 7, 2019Feb 12, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 25, 2021May 5, 2021Aug 5, 2021Nov 15, 2021Mar 29, 2022May 16, 2022Aug 11, 2022Nov 8, 2022Mar 3, 2023May 9, 2023Aug 4, 2023Nov 13, 2023Mar 29, 2024May 14, 2024Aug 6, 2024Nov 12, 2024Mar 27, 2025May 14, 2025Aug 8, 2025Nov 19, 2025May 29, 2026Aug 19, 2026Nov 18, 2026
EPS Estimate0.00-26.67-1062.50-18.50-1157.39-1233.33-1600.00-26.10-2013.42-1853.70-1619.39-1556.46-1500.00-942.49-1134.23-22.92-1108.33-975.30-978.61-20.33-720.10-900.001450.00-382.50-4.52-214.5023.00-200.00-2.89-229.00-135.50-2.47-127.00-102.00-50.50---
EPS Actual-0.57-465.00-1400.00-23.00-1150.00-1500.00-1575.00-38.00-1875.00-1750.00-1700.00-1575.00-1350.00-1050.00-1250.00-27.50-1025.00-1000.00-925.00-34.00-1001.00-872.50-449.33-323.17-6.99-174.05-150.12-79.07-4.19-122.27-96.50-1.23-50.66-65.94-53.50-0.14-21.32-
Surprise--1643.53%-31.76%-24.32%0.64%-21.62%1.56%-45.59%6.87%5.59%-4.98%-1.19%10.00%-11.41%-10.21%-19.98%7.52%-2.53%5.48%-67.24%-39.01%3.06%-130.99%15.51%-54.65%18.86%-752.70%60.47%-44.98%46.61%28.78%50.14%60.11%35.35%-5.94%---
Timing-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-market---

Key Statistics & Ratios

Market Cap9.20M
Enterprise Value3.27M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales23.75
Price / Book1.20
EPS-9.39
Book Value0.468
Revenue (TTM)0
Gross Profit (TTM)1.33M
EBITDA-24.07M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-345.32%
Return on Assets-65.43%
Shares Outstanding19.34M
Shares Float19.34M
Beta-2.29
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 1.50
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
4.07%
Insiders
1.24%
Retail / Other
94.69%

Top Institutional Holders

  • Renaissance Technologies Corp
    417.52K0.04%
  • Geode Capital Management, LLC
    261.06K0.03%
  • Virtu Financial LLC
    152.20K0.02%
  • ADAR1 Capital Management LLC
    141.48K0.01%
  • UBS Group AG
    66.87K0.01%
  • Vanguard Capital Management, LLC
    60.55K0.01%
  • Jane Street Group LLC
    36.00K0.00%
  • JPMorgan Chase & Co
    30.02K0.00%
  • Vanguard Fiduciary Trust Co
    29.63K0.00%
  • State Street Corp
    28.58K0.00%
  • LPL Financial Corp
    17.23K0.00%
  • The Goldman Sachs Group Inc
    14.05K0.00%
  • StoneX Group Inc
    12.98K0.00%
  • Northern Trust Corp
    11.52K0.00%
  • BlackRock Inc
    10.81K0.00%

Top Fund Holders

  • Fidelity Extended Market Index
    96.49K17.32%
  • Fidelity Total Market Index
    19.20K3.45%
  • Fidelity Series Total Market Index
    17.40K3.12%
  • Fidelity Nasdaq Composite Index
    12.83K2.30%
  • JHVIT Total Stock Market Index I
    3550.06%

Stock Splits

  • May 11, 20261:50
  • Oct 21, 20221:50